Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy (Q33894498)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

anti-retroviral agent

0 references

United States of America

0 references

1 reference

based on heuristic

inferred from title

opportunistic infection

1 reference

based on heuristic

inferred from title

Mary Lou Lindegren

6

object named as

M L Lindegren

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

J E Kaplan

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

D Hanson

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

M S Dworkin

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

T Frederick

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J Bertolli

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S Holmberg

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

J L Jones

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

1 April 2000

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

30 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

S5-14

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Natural history of opportunistic disease in an HIV-infected urban clinical cohort

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Gender differences in reported AIDS-indicative diagnoses

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Racial differences in the use of drug therapy for HIV disease in an urban community

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1086%2F313843

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33894498&oldid=1983509619"